However, we believe that a reasonable approach is to first explore the mechanism(s) behind the aggressive behavior of BRAFi-R melanoma cells and then study how the addition of a MEK inhibitor modulates such a modification(s). This evidence concerns the gene MAP2K7 and melanoma.